CD79b Antikörper (SPRD)

Produktnummer ABIN376740

Dieser Anti-CD79b Antikörper ist ein Maus Monoklonal Antikörper zur Detektion von CD79b in FACS. Geeignet für Human.

Kurzübersicht für CD79b Antikörper (SPRD) (ABIN376740)

Target: CD79b (CD79B) (CD79b Molecule, Immunoglobulin-Associated beta (CD79B))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser CD79b Antikörper ist konjugiert mit SPRD

Applikation: Flow Cytometry (FACS)

Klon: CB3-1

Produktdetails anti-CD79b Antikörper (SPRD)

Spezifität: Human CD79b, Mr 37 kDa

Produktmerkmale: Mouse Anti-Human CD79b-SPRD

Aufreinigung: Purified

Immunogen: Ramos B cells

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise:

• Applications: FC - Quality tested , IP - Reported in literature , WB - Reported in literature
• Working Dilutions: Flow Cytometry Purified (UNLB) antibody 1 g/106 cells FITC, BIOT, PE, APC, and SPRD conjugates 10 L/106 cells For flow cytometry, the suggested use of these reagents is in a final volume of 100 L

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: 100 tests in 1.0 mL of PBS/Sodium azide and a stabilizing agent

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Do not freeze!
Protect conjugated products from light.
Each reagent is stable for the period shown on the bottle label if stored as directed.

Lagerung: 4 °C

Informationen zur Lagerung: Store at 2-8°C

Details zu CD79b

Target: CD79b (CD79B) (CD79b Molecule, Immunoglobulin-Associated beta (CD79B))

Andere Bezeichnung: CD79b

Hintergrund: CD79 is a 23/21 disulfide-linked heterodimer composed of an α chain (CD79a/mb-1) and a β chain (CD79b/B29) that associates non-covalently with membrane immunoglobulin to form the B cell receptor (BCR) complex. Its expression is restricted to B lymphocytes, first appearing on the surface at the pro-B cell stage and remaining through all stages of B cell differentiation prior to plasma cells. Crosslinking of the BCR leads to B cell activation.

Pathways: BCR Signaling